The effect of vascular endothelial growth factor (VEGF) presentation within fibrin matrices on endothelial cell branching

Biomaterials

Volumn 32, Issue 30, 2011, Pages 7432-7443

  Anderson, Sean M ^a   Siegman, Shayne N ^a   Segura, Tatiana ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiogenesis; Endothelial cell; Fibrin; Growth factors; Heparin; Nanoparticle

Indexed keywords

ANGIOGENESIS; CHORIOALLANTOIC MEMBRANE ASSAYS; COVALENTLY BOUND; FIBRIN; FIBRIN GELS; FIBRIN MATRIX; FIBROBLAST CELLS; GROWTH FACTOR; GROWTH FACTORS; HEPARIN; HIGH DENSITY; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; IN-VIVO; LOW DENSITY; NANO DOMAIN; TISSUE IMPLANTS; TUBE FORMATION; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

BLOOD VESSELS; CAMS; CELL CULTURE; NANOPARTICLES; NETWORK ARCHITECTURE; PEPTIDES; SCAFFOLDS (BIOLOGY); TISSUE;

ENDOTHELIAL CELLS;

FIBRIN; HEPARIN; NANOPARTICLE; POLYMER; POLYSTYRENE; TISSUE SCAFFOLD; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CHORIOALLANTOIS; CONTROLLED STUDY; COVALENT BOND; ENVIRONMENT; FIBROBLAST; GEL; HUMAN; HUMAN CELL; HYDROGEL; IN VIVO STUDY; PHYSIOLOGY; PRIORITY JOURNAL; STATIC ELECTRICITY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION;

CELL LINE; CELL MOVEMENT; ENDOTHELIAL CELLS; FIBRIN; HEPARIN; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; NANOPARTICLES; NEOVASCULARIZATION, PHYSIOLOGIC; POLYSTYRENES; TISSUE SCAFFOLDS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 80051547838     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.06.027     Document Type: Article

References (37)

1. Lanza R.P., Langer R.S., Vacanti J. Principles of tissue engineering 2007, Elsevier Academic Press, Boston. 3rd ed.
2. Novosel E.C., Kleinhans C., Kluger P.J. Vascularization is the key challenge in tissue engineering. Adv Drug Deliv Rev 2011, 10.1016/j.addr.2011.03.004.
3. Kannan R.Y., Salacinski H.J., Sales K., Butler P., Seifalian A.M. The roles of tissue engineering and vascularisation in the development of micro-vascular networks: a review. Biomaterials 2005, 26:1857-1875.
4. Gu F., Amsden B., Neufeld R. Sustained delivery of vascular endothelial growth factor with alginate beads. J Control Release 2004, 96:463-472.
5. Huang M., Vitharana S.N., Peek L.J., Coop T., Berkland C. Polyelectrolyte complexes stabilize and controllably release vascular endothelial growth factor. Biomacromolecules 2007, 8:1607-1614.
6. Edelman E.R., Mathiowitz E., Langer R., Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 1991, 12:619-626.
7. Ehrbar M., Djonov V.G., Schnell C., Tschanz S.A., Martiny-Baron G., Schenk U., et al. Cell-demanded liberation of VEGF121 from fibrin implants induces local and controlled blood vessel growth. Circ Res 2004, 94:1124-1132.
8. Zisch A.H., Lutolf M.P., Ehrbar M., Raeber G.P., Rizzi S.C., Davies N., et al. Cell-demanded release of VEGF from synthetic, biointeractive cell ingrowth matrices for vascularized tissue growth. FASEB J 2003, 17:2260-2262.
9. Joung Y.K., Bae J.W., Park K.D. Controlled release of heparin-binding growth factors using heparin-containing particulate systems for tissue regeneration. Expert Opin Drug Deliv 2008, 5:1173-1184.
10. Lee J., Lee K.Y. Local and sustained vascular endothelial growth factor delivery for angiogenesis using an injectable system. Pharm Res 2009, 26:1739-1744.
11. Zieris A., Prokoph S., Levental K.R., Welzel P.B., Grimmer M., Freudenberg U., et al. FGF-2 and VEGF functionalization of starPEG-heparin hydrogels to modulate biomolecular and physical cues of angiogenesis. Biomaterials 2010, 31:7985-7994.
12. King T.W., Patrick C.W. Development and in vitro characterization of vascular endothelial growth factor (VEGF)-loaded poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) microspheres using a solid encapsulation/single emulsion/solvent extraction technique. J Biomed Mater Res 2000, 51:383-390.
13. Chung Y.I., Kim S.K., Lee Y.K., Park S.J., Cho K.O., Yuk S.H., et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. J Control Release 2010, 143:282-289.
14. Fairbrother W.J., Champe M.A., Christinger H.W., Keyt B.A., Starovasnik M.A. Solution structure of the heparin-binding domain of vascular endothelial growth factor. Structure 1998, 6:637-648.
15. Lee S., Jilani S.M., Nikolova G.V., Carpizo D., Iruela-Arispe M.L. Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors. J Cell Biol 2005, 169:681-691.
16. Moon J.J., Saik J.E., Poche R.A., Leslie-Barbick J.E., Lee S.H., Smith A.A., et al. Biomimetic hydrogels with pro-angiogenic properties. Biomaterials 2010, 31:3840-3847.
17. Phelps E.A., Landazuri N., Thule P.M., Taylor W.R., Garcia A.J. Bioartificial matrices for therapeutic vascularization. Proc Natl Acad Sci U S A 2010, 107:3323-3328.
18. Anderson S.M., Chen T.T., Iruela-Arispe M.L., Segura T. The phosphorylation of vascular endothelial growth factor receptor-2 (VEGFR-2) by engineered surfaces with electrostatically or covalently immobilized VEGF. Biomaterials 2009, 30:4618-4628.
19. Nakatsu M.N., Davis J., Hughes C.C. Optimized fibrin gel bead assay for the study of angiogenesis. J Vis Exp 2007, 3:186.
20. Nakatsu M.N., Sainson R.C., Perez-del-Pulgar S., Aoto J.N., Aitkenhead M., Taylor K.L., et al. VEGF(121) and VEGF(165) regulate blood vessel diameter through vascular endothelial growth factor receptor 2 in an in vitro angiogenesis model. Lab Invest 2003, 83:1873-1885.
21. Phelps E.A., Garcia A.J. Engineering more than a cell: vascularization strategies in tissue engineering. Curr Opin Biotechnol 2010, 21:704-709.
22. Missirlis D., Tirelli N., Hubbell J.A. Amphiphilic hydrogel nanoparticles. Preparation, characterization, and preliminary assessment as new colloidal drug carriers. Langmuir 2005, 21:2605-2613.
23. Chen T.T., Luque A., Lee S., Anderson S.M., Segura T., Iruela-Arispe M.L. Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cells. J Cell Biol 2010, 188:595-609.
24. Takahashi T., Yamaguchi S., Chida K., Shibuya M. A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells. EMBO J 2001, 20:2768-2778.
25. Dayanir V., Meyer R.D., Lashkari K., Rahimi N. Identification of tyrosine residues in vascular endothelial growth factor receptor-2/FLK-1 involved in activation of phosphatidylinositol 3-kinase and cell proliferation. J Biol Chem 2001, 276:17686-17692.
26. Fujio Y., Walsh K. Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem 1999, 274:16349-16354.
27. Lamalice L., Houle F., Jourdan G., Huot J. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38. Oncogene 2004, 23:434-445.
28. Rousseau S., Houle F., Landry J., Huot J. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells. Oncogene 1997, 15:2169-2177.
29. Mori M., Murata Y., Kotani T., Kusakari S., Ohnishi H., Saito Y., et al. Promotion of cell spreading and migration by vascular endothelial-protein tyrosine phosphatase (VE-PTP) in cooperation with integrins. J Cell Physiol 2010, 224:195-204.
30. Gerhardt H., Golding M., Fruttiger M., Ruhrberg C., Lundkvist A., Abramsson A., et al. VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia. J Cell Biol 2003, 161:1163-1177.
31. Krueger J., Liu D., Scholz K., Zimmer A., Shi Y., Klein C., et al. Flt1 acts as a negative regulator of tip cell formation and branching morphogenesis in the zebrafish embryo. Development 2011, 138:2111-2120.
32. Ruhrberg C., Gerhardt H., Golding M., Watson R., Ioannidou S., Fujisawa H., et al. Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis. Genes Dev 2002, 16:2684-2698.
33. Laise P., Di Patti F., Fanelli D., Masselli M., Arcangeli A. Deterministic and stochastic aspects of VEGF-A production and the cooperative behavior of tumoral cell colony. J Theor Biol 2011, 272:55-63.
34. Hubbell J.A. Matrix-bound growth factors in tissue repair. Swiss Med Wkly 2006, 136:387-391.
35. Xie Y., Upton Z., Richards S., Rizzi S.C., Leavesley D.I. Hyaluronic acid: evaluation as a potential delivery vehicle for vitronectin:growth factor complexes in wound healing applications. J Control Release 2011, 10.1016/j.jconrel.2011.03.021.
36. Lei Y., Huang S., Sharif-Kashani P., Chen Y., Kavehpour P., Segura T. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. Biomaterials 2010, 31:9106-9116.
37. Rayavarapu R.G., Petersen W., Hartsuiker L., Chin P., Janssen H., van Leeuwen F.W., et al. In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology 2010, 21:145101.